Literature DB >> 24788006

Spontaneous relocation of a trapped retrolenticular slow-release dexamethasone implant (Ozurdex) in a silicone oil-filled eye of a pseudophakic patient.

P J Banerjee1, P Petrou1, T M Zvobgo1, D G Charteris1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24788006      PMCID： PMC4135265          DOI： 10.1038/eye.2014.84

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

1.  Anterior vitreous displacement of the intravitreal dexamethasone implant (Ozurdex).

Authors:  S Wai Ch'ng; S Padroni; S Banerjee
Journal:  Eye (Lond)       Date:  2013-12-13       Impact factor: 3.775

2.  Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis.

Authors:  Careen Lowder; Rubens Belfort; Sue Lightman; C Stephen Foster; Michael R Robinson; Rhett M Schiffman; Xiao-Yan Li; Harry Cui; Scott M Whitcup
Journal:  Arch Ophthalmol       Date:  2011-01-10

3.  Dexamethasone intravitreal implant in the silicone oil-filled eye for the treatment for recurrent macular oedema associated with ankylosing spondylitis: a case report.

Authors:  Jee T Kim; Young H Yoon; Dong H Lee; Soo G Joe; June-G Kim
Journal:  Acta Ophthalmol       Date:  2013-02-11       Impact factor: 3.761

4.  Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.

Authors:  David S Boyer; David Faber; Sunil Gupta; Sunil S Patel; Homayoun Tabandeh; Xiao-Yan Li; Charlie C Liu; Jean Lou; Scott M Whitcup
Journal:  Retina       Date:  2011-05       Impact factor: 4.256

5.  Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Authors:  Julia A Haller; Francesco Bandello; Rubens Belfort; Mark S Blumenkranz; Mark Gillies; Jeffrey Heier; Anat Loewenstein; Young-Hee Yoon; Marie-Louise Jacques; Jenny Jiao; Xiao-Yan Li; Scott M Whitcup
Journal:  Ophthalmology       Date:  2010-04-24       Impact factor: 12.079

6.  Ozurdex (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial.

Authors:  Philip J Banerjee; Catey Bunce; David G Charteris
Journal:  Trials       Date:  2013-10-28       Impact factor: 2.279
  6 in total
  2 in total

1.  Location of a Dexamethasone Implant at the Macula after Intravitreal Injection in a Silicone Oil-Filled Eye.

Authors:  Cenap Mahmut Esenulku; Murat Gunay
Journal:  Case Rep Ophthalmol Med       Date:  2016-11-23

2.  RETAINED, NONDISSOLVING, TUBULAR FOREIGN BODIES IN THE VITREOUS CAVITY AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) IMPLANTATION.

Authors:  Ian C Han; D Brice Critser; Alec L Amram; James C Folk
Journal:  Retina       Date:  2020-11       Impact factor: 3.975
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.